Disclosure Panels Details Page
Non-Hodgkin`s Lymphomas Panel - Disclosures as of 10/31/2014
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Jeremy Abramson MD, MMSc | Celgene Corporation Constellation, Inc. Gilead Millennium Pharmaceuticals, Inc. Novartis Pharmaceuticals Corporation Onyx Pharmaceuticals, Inc. Pharmacyclics Seattle Genetics |
Amgen Inc. Gilead Infinity Pharmaceuticals Millennium Pharmaceuticals, Inc. |
Millennium Pharmaceuticals, Inc. | None | - |
| Ranjana Advani MD | Agensys, Inc. Allos Therapeutics, Inc. Celgene Corporation Genentech, Inc. Idera Pharmaceuticals Millennium Pharmaceuticals, Inc. Pharmacyclics Seattle Genetics |
Clarient Genentech, Inc. Millennium Pharmaceuticals, Inc. Seattle Genetics |
None | None | - |
| Babis Andreadis MD, MSCE | GSK | None | Millennium Pharmaceuticals, Inc. Pharmacyclics Spectrum |
None | - |
| Nancy Bartlett MD | AstraZeneca Pharmaceuticals LP Celgene Corporation Genentech, Inc. MedImmune Inc. Millennium Pharmaceuticals, Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. Pharmacyclics Seattle Genetics |
None | Gilead Seattle Genetics |
None | ✔ |
| Marian Birkeland PhD | None | None | None | None | ✔ |
| John Byrd MD | None | None | Genentech, Inc. Pharmacyclics |
None | ✔ |
| Myron Czuczman MD | Celgene Corporation Gilead Onyx Pharmaceuticals, Inc. |
Algeta Boehringer Ingelheim GmbH Celgene Corporation Gilead Millennium Pharmaceuticals, Inc. MorphoSys Mundipharma T G Therapeutics Teva |
None | None | - |
| Mary Dwyer MS | None | None | None | None | ✔ |
| Luis Fayad MD | Centocor, Inc. Eisai Inc. Eli Lilly and Company Genentech, Inc. GSK Novartis Pharmaceuticals Corporation Pfizer Inc. Roche Laboratories, Inc. sanofi-aventis U.S. Wyeth Pharmaceuticals |
None | None | None | - |
| Richard Fisher MD | None | Coherus Bioscience Giliad Johnson & Johnson |
None | None | ✔ |
| Lauren Gallagher | None | None | None | None | ✔ |
| Martha Glenn MD | Amgen Inc. Institutional DSMC sanofi-aventis U.S. |
None | None | None | - |
| Leo Gordon MD | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Thomas Habermann MD | None | None | None | None | ✔ |
| Nancy Lee Harris MD | Pharmacyclics | None | None | None | ✔ |
| Richard Hoppe MD | None | Clarient | Clarient | None | - |
| Steven Horwitz MD | Celgene Corporation Infinity Kiowa-Kirin Millennium Pharmaceuticals, Inc. Seattle Genetics spectrum |
Actelion Pharmaceuticals US, Inc. Amgen Inc. Bristol Myers Squibb Celgene Corporation Kiowa Hakka Kirin Millennium Pharmaceuticals, Inc. Spectrum |
Celgene Corporation | None | - |
| Christopher Kelsey MD | Varian Medical Systems, Inc. | None | None | None | ✔ |
| Youn Kim MD | Eisai Inc. Genentech, Inc. KHK Millennium Pharmaceuticals, Inc. Seattle Genetics SHAPE |
Actelion Pharmaceuticals US, Inc. Celgene Corporation Eisai Inc. Galderma Millennium Pharmaceuticals, Inc. |
None | None | - |
| Susan Krivacic MPAff | None | None | None | None | ✔ |
| Ann LaCasce MD, MMSc | None | GSK | None | None | ✔ |
| Joan McClure MS | None | None | None | None | ✔ |
| Auayporn Nademanee MD | Celgene Seattle Genetics Co. |
None | None | None | ✔ |
| Elise Olsen MD | Eisai Inc. | None | Actelion Pharmaceuticals US, Inc. | None | - |
| Pierluigi Porcu MD | Infinity OncoMed Seattle Genetics |
Actelion Pharmaceuticals US, Inc. Celgene Corporation KIOWA Kirin |
Actelion Pharmaceuticals US, Inc. Celgene Corporation |
None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | ✔ |
| Oliver Press MD, PhD | Genentech, Inc. Roche Laboratories, Inc. |
Adaptive Biotechnologies Algeta |
None | Emergent Biosolutions | ✔ |
| Rachel Rabinovitch MD | RTOG Data Safety and Monitoring Board | Accuray Incorporated | None | None | - |
| Nishitha Reddy MD | Celgene Corporation | None | None | None | ✔ |
| Erin Reid MD | AbbVie, Inc. AIDS Malignancy Consortium Bristol Myers Squibb CALGB/CTSU Isis Millennium Pharmaceuticals, Inc. Pharmacyclics Takeda Pharmaceuticals North America, Inc. |
None | None | None | ✔ |
| Ayman Saad MD | None | ICARE IMS Consulting Group |
None | None | - |
| Lubomir Sokol MD, PhD | None | Alexion Pharmaceuticals, Inc. Celgene Corporation Spectrum |
Onyx Pharmaceuticals, Inc. | None | - |
| Hema Sundar PhD | None | None | None | None | ✔ |
| Lode Swinnen MBChB | Abbott Laboratories | None | None | None | - |
| Sarika Trikha PharmD | None | None | None | None | ✔ |
| Christina Tsien MD | None | None | None | None | - |
| Julie Vose MD, MBA | Bristol Myers Squibb Celgene Corporation Genentech, Inc. GSK Incyte Onyx Pharmaceuticals, Inc. Pharmacyclics sanofi-aventis U.S. US Biotest US Biotest, Inc. |
None | None | None | - |
| William Wierda MD, PhD | Abbott Laboratories GSK |
Celgene Corporation Genentech, Inc. Roche Laboratories, Inc. |
None | None | ✔ |
| Lynn Wilson MD | None | None | None | Amgen Inc. |Biogen Idec|Bristol Myers Squibb|Celgene Corporation|GSK|Immunogen|ISIS|Merck & Co., Inc.|Novartis Pharmaceuticals Corporation |Teva pharma|UCAN|UnitedHealthcare|Vertex Pharmaceuticals Incorporated | ✔ |
| Joachim Yahalom MD | None | None | None | None | - |
| Nadeem Zafar MD | None | None | None | None | ✔ |
| Andrew Zelenetz MD, PhD | Abbott Laboratories Boehringer Ingelheim GmbH Celgene Corporation Constellation Pharmaceuticals Curis Genentech, Inc. Gilead GSK Infinity Novartis Pharmaceuticals Corporation Onyx Pharmaceuticals, Inc. Seattle Genetics |
Amgen Inc. Bullet Bio Technology Cancer Genetics Celgene Corporation Dr. Reddy`s Laboratories Emergent Biosolutions Foundation Medicine Genentech, Inc. Gilead Hospira Roche Laboratories, Inc. sanofi-aventis U.S. |
None | None | ✔ |